Current Biology Response to Reviewers: How to Write a Rebuttal That Wins (2026)

The first move in a Current Biology rebuttal happens before you write a word. Cell Press uses a consulting-editor model in which the editor synthesizes the reviewer reports into one decision letter and outlines the type of revision expected. Read that letter for what the editor made mandatory, not the union of every reviewer request.

If the letter is not explicit about which experiments are essential, email the handling editor at currentbio@cell.com and ask. Editors expect this. The alternative, running every reviewer's wish-list experiment, can cost you months and still miss the revision the editor actually wanted.

State the exact page and line number for each manuscript revision, and reference the specific figure, table, or STAR Methods subsection you changed. This is the single most-cited rebuttal failure at Current Biology and across Cell Press. A reviewer who has to hunt for your change reads it as evasion. A reviewer who can click straight to page 7, lines 18 to 24, and see the new control finishes faster and re-reviews more favorably.

Never write "we have addressed this in the manuscript" without a location. Use the line numbers from the revised file, not the original, and name the STAR Methods subsection (Resource Availability, Experimental Model and Subject Details, or Quantification and Statistical Analysis) when the change lives there.

The reviewers see your tone across every comment, and Cell Press runs cross-consultation where reviewers discuss each other's reports with the editor. A defensive reply to Reviewer 1 is visible to Reviewers 2 and 3. Calibrate.

The pattern that works: concede where the reviewer is right, do the work the editor scoped, point to the exact change, and push back only on a request that is genuinely out of scope, with a reason and an alternative.

Current Biology is editor-scoped: a Cell Press consulting editor, a professional editor rather than an academic editor, owns the decision, reads the whole paper, and writes one decision letter that outlines the type of revision expected. A consulting editor at the title handles a heavy quarterly load and spends roughly 30 to 60 minutes on the initial read, so the editor's synthesis, not any single reviewer's line, defines what your revision must demonstrate.

External peer review typically uses 2 to 3 reviewers, and Cell Press runs cross-consultation among reviewers, where referees discuss each other's reports with the editor before the decision. At the revision stage, your rebuttal is therefore a group document read against a scoped decision letter, not a private exchange with one referee.

SciRev community data on Cell Press journals puts the first review round at roughly 1.2 months, and Current Biology's own ScienceDirect insights show about 140 days from submission to acceptance once the revision cycle is counted, which sets your planning clock for the work you are about to do.

A defining feature is the transparent peer review option. When a paper is accepted, Cell Press can publish the reviewer reports and your author responses alongside the article if you opt in, with reviewers anonymous unless they choose to sign. The practical consequence: write your response to reviewers as a document that future readers, competitors, and grant panels may read. A rebuttal that is sloppy, evasive, or dismissive can become part of your published record. A rebuttal that concedes cleanly and shows new data becomes evidence of rigor.

A major revision at Current Biology carries a specific meaning. It typically requires new experiments or substantial reanalysis, and, because the journal's filter is general-interest biology, it also requires a sharper broad-biology story. Adding data without sharpening the framing is a common way to clear the reviewers' technical points and still miss the editor's bar. So the real target is two-part: do the bench work the editor scoped, and rewrite the summary and Discussion so the result reads as biology a non-specialist will care about.

How this compares to the rest of Cell Press matters for calibration. A response at Cell faces a flagship novelty bar and the heaviest mechanistic-depth demand, while Molecular Cell wants molecular mechanism resolved to the last step, and Cell Reports tolerates a narrower advance.

Current Biology sits apart on a different axis: its bar is breadth of biological interest, so a rebuttal that deepens mechanism but never widens the story can satisfy a Molecular Cell reviewer and still fail at Current Biology. Write the revision toward broad legibility, not just toward more data.

In our pre-submission review work with Current Biology submissions, the rebuttals that stall in a second revision round share a small set of recurring weaknesses. These are the same ones reviewers flag at re-review, and because the exchange can be published, they can also become part of the permanent record. In our analysis of Current Biology rebuttals, each weakness below maps to a specific, named failure pattern in the Cell Press editorial culture, and each is testable against your own draft response before you upload it.

Running every reviewer experiment instead of asking the editor to scope. The most expensive pattern in our Current Biology pre-submission reviews is a rebuttal that attempts the full union of every reviewer's requested experiment rather than the revision the consulting editor actually scoped. Cell Press editors write one decision letter that outlines the type of revision expected; treating it as a checklist of all reviewer demands burns months on bench work the editor never required.

Across our Current Biology rebuttal reviews, authors who emailed the editor to confirm which controls and analyses were mandatory finished a round faster than authors who tried to satisfy everyone.

Adding data but not the requested broad-biology framing. Because Current Biology's filter is general-interest biology, a rebuttal that resolves the technical methods points but leaves the summary and Discussion reading like a subfield paper misses the editor's actual bar. In our Current Biology pre-submission reviews we routinely see a revision that adds the requested figure and reanalysis yet never rewrites the framing to state why a non-specialist should care. The reviewers' technical comments get answered; the editor's significance concern does not. Rewrite the story, not only the data.

Conceding the central claim while defending peripheral points. A rebuttal that softens the paper's core hypothesis to placate one reviewer while arguing hard over a minor stylistic note reads as misplaced effort. In our pre-submission review work with Current Biology manuscripts, we flag responses that hedge the headline finding into a weaker claim, which then fails the broad-significance bar, while spending paragraphs defending a peripheral statistical analysis choice. Defend the central claim with new evidence and the editor's scoped experiments; let the small stuff go.

Generic acknowledgment with no STAR Methods location. A rebuttal that says "we have revised the manuscript accordingly" forces the reviewer to hunt for the change, and at Current Biology a methods or reproducibility fix that is not pointed to its STAR Methods subsection is read as incomplete. In our Current Biology pre-submission reviews, responses that omit the page, line, and named supplementary or STAR Methods location consistently draw a re-review comment asking where the change is, which adds a round.

Scope the revision with the editor, rewrite the story for breadth, defend the central claim, and locate every change in STAR Methods. That four-part discipline is what separates a Current Biology rebuttal that clears one revision round from one that stalls into a second or third. Check your Current Biology point-by-point response for these patterns before you submit.

Source: Manusights pre-submission reviews of Current Biology-targeted resubmissions, 2025 cohort.

Authors consistently underestimate the new-data effort and the story-rewriting effort, and overestimate the per-comment writing. This breakdown is about workload, not the journal's decision clock; for the end-to-end decision schedule, see the Current Biology review time guide.

Source: Manusights pre-submission reviews of Current Biology resubmissions, 2025 cohort, last updated June 7, 2026.

A major-revision invitation at Current Biology is not a soft acceptance. The revised manuscript and your point-by-point response go back to the original reviewers, who discuss each other's reports with the editor, and the paper can still end in rejection after re-review if the new data and the sharper story do not resolve the core concern.

Current Biology's reviewed-manuscript acceptance rate sits in the rough range of 30 to 40 percent, which tells you the journal does not rubber-stamp revisions. Most rejections at this stage trace to one cause: the author added data but never widened the broad-biology framing the editor asked for. The second most common is running the full reviewer wish-list without confirming scope, then arriving with the wrong experiments.

Think twice before you resubmit if any of these are true. The response uses generic "we have addressed this" language with no page, line, or STAR Methods location. A reviewer asked for a new experiment and you answered with text. You added data but never rewrote the summary for breadth. You ran every reviewer request without confirming with the editor which were mandatory. Fixing these before resubmission is what keeps a second round from becoming a rejection.

The official guidelines tell you to submit a point-by-point response and to complete the STAR Methods and Resource Availability sections. They do not tell you that the revision is editor-scoped, that you should confirm which experiments are mandatory before running them, that the bar is broad-biology legibility rather than mechanistic depth alone, or that the exchange may be published under transparent peer review. Those four facts change how you write every reply.

The patterns above come from our pre-submission reviews of Current Biology rebuttals, and they are testable against your own draft today, not theoretical concerns.

• Manusights pre-submission reviews of Current Biology-targeted manuscripts (2025 cohort)